<p>添加</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>作為您在 Google 上的首選新聞來源</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>立即添加</p>
<p>SciSparc Ltd. (SPRC) 週二宣佈與 Xylo Technologies Ltd. 達成一項最終協議，收購一系列專利、商標和知識產權，涉及創新的內窺鏡系統和醫療相機，包括 MUSE 系統。</p>
<p>公司將向 Xylo 發行一定數量的普通股，以作為收購資產的對價。</p>
<p>交易完成後，SciSparc 打算立即開始這些專利技術的商業化，預計將促進快速市場滲透和收入生成。</p>
<p>在盤前交易時，SPRC 上漲 21.3%，至 1.76 美元，納斯達克上市。</p>
<p>如有意見和反饋，請聯繫：editorial@rttnews.com</p>
<p>商業新聞</p>

SPRC

<p>SciSparc Ltd. (SPRC) 宣佈與 Xylo Technologies Ltd. 達成一項最終協議，收購內窺鏡系統和醫療攝像頭的專利及知識產權。該公司將以普通股作為資產的對價。在交易完成後，SciSparc 計劃將這些技術商業化，以增強市場滲透率和收入。在盤前交易中，SPRC 股價上漲 21.3%，達到 1.76 美元，交易所為納斯達克</p>

<p>Add</p>
<div class="lb-trans"><p>添加</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png" alt="" original-src="https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>as your preferred news source on Google</p>
<div class="lb-trans"><p>作為您在 Google 上的首選新聞來源</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png" alt="" original-src="https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>Add Now</p>
<div class="lb-trans"><p>立即添加</p>
</div><p>SciSparc Ltd. (SPRC), Tuesday announced a definitive agreement to acquire a treasury of patents, trademarks and intellectual property rights for innovative endoscopic systems and medical cameras, including the MUSE system, from Xylo Technologies Ltd.</p>
<div class="lb-trans"><p>SciSparc Ltd. (SPRC) 週二宣佈與 Xylo Technologies Ltd. 達成一項最終協議，收購一系列專利、商標和知識產權，涉及創新的內窺鏡系統和醫療相機，包括 MUSE 系統。</p>
</div><p>The company will issue an amount of its common shares to Xylo in consideration for the acquired assets.</p>
<div class="lb-trans"><p>公司將向 Xylo 發行一定數量的普通股，以作為收購資產的對價。</p>
</div><p>Upon closing of the deal, SciSparc intends to commence commercialization of these patented technologies immediately, which is expected to boost rapid market penetration and revenue generation.</p>
<div class="lb-trans"><p>交易完成後，SciSparc 打算立即開始這些專利技術的商業化，預計將促進快速市場滲透和收入生成。</p>
</div><p>In the pre-market hours, SPRC is moving up 21.3 percent, to $1.76 on the Nasdaq.</p>
<div class="lb-trans"><p>在盤前交易時，SPRC 上漲 21.3%，至 1.76 美元，納斯達克上市。</p>
</div><p>For comments and feedback contact: editorial@rttnews.com</p>
<div class="lb-trans"><p>如有意見和反饋，請聯繫：editorial@rttnews.com</p>
</div><p>Business News</p>
<div class="lb-trans"><p>商業新聞</p>
</div>

SciSparc 將收購內窺鏡系統和醫用攝像機的知識產權